GLI1-Altered Mesenchymal Tumors

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• GLI1-altered mesenchymal tumors represent an emerging class of neoplasms.
• These tumors are defined by genetic alterations (fusions or amplifications) in the GLI1 gene, a critical component of the Hedgehog signaling pathway.
• They have been identified across diverse anatomical locations and age groups.

Purpose of the Study:

• To characterize the emerging group of GLI1-altered mesenchymal tumors.
• To describe their morphological and immunophenotypic spectrum.
• To evaluate their metastatic potential and classification.

Main Methods:

• Review of existing literature and case reports on GLI1-altered mesenchymal tumors.
• Analysis of morphological features, immunophenotypes, and genetic alterations (GLI1 fusions/amplifications).
• Assessment of clinical data, including anatomical site, age range, and metastatic behavior.

Main Results:

• GLI1-altered tumors present a wide morphologic spectrum but often show monomorphic ovoid cells in nests with a prominent vascular network.
• These neoplasms occur in various anatomic sites and affect a broad age range.
• Evidence suggests these tumors possess metastatic potential.

Conclusions:

• GLI1-altered mesenchymal tumors are a distinct emerging entity.
• Their histological and genetic characteristics, coupled with metastatic potential, support their classification as sarcomas.
• Further research is warranted to fully understand these neoplasms.